Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cancer. 2010 Oct 19;117(6):1113–1122. doi: 10.1002/cncr.25527

Table 2.

Risk of Event Versus Probability of Achieving a Complete Cytogenetic Response According to Molecular Response at Specific Time Points32

BCR-ABL1/ABL1 Transcript Ratio Percentage Probability of Outcome According to Transcript Ratio at Specified Time Points (Median Months to Outcome)
MMR (BCR-ABL1/ABL1 <0.05%) Event
3 mo 6 mo 12 mo 3 mo 6 mo 12 mo
≤0.1% 100 (3) 96 (6) 97 (12) 4 (13) 1 (38) 3 (40)
>0.1% to 1% 84 (6) 69 (12) 61 (18) 3 (46) 7 (30) 2 (48)
>1% to 10% 53 (17) 44 (18) 20 (33) 11 (21) 9 (34) 8 (47)
>10% 33 (15) 15 (18) 7 (46) 13 (47) 23 (14) 50 (19)

MMR indicates major molecular response; mo, months.